{"id":51488,"date":"2022-12-02T00:02:32","date_gmt":"2022-12-01T23:02:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/"},"modified":"2022-12-02T00:02:32","modified_gmt":"2022-12-01T23:02:32","slug":"merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/","title":{"rendered":"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–MERGE<\/a>, a premium storytelling and technology company, is proud to announce that Kristen Henkins Ambegaokar, PhD, Medical Director, Life Sciences, has been named to MM+M\u2019s fourth class of 40 Under 40 honorees.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe 40 Under 40 list includes individuals who hail from a range of employers, from pharma and biotech companies and agencies to device manufacturers, analytics firms and health media. At those organizations, the honorees hold a range of essential account, strategy and creative positions. With the world of medical marketing continuing to evolve in the digital era, these individuals inspire confidence that the industry is in good hands for the years ahead.\n<\/p>\n

\n\u201cAmong the many reasons the medical marketing business continues to thrive is the abundance of top-flight talent in its ranks. Other verticals are jealous, frankly,\u201d said MM+M editor-in-chief Larry Dobrow. \u201cOf course, that makes the 40 Under 40 selection process a challenge \u2013 but it\u2019s one that we embrace. It\u2019s a privilege to celebrate the individuals set to lead the business for years to come.\u201d\n<\/p>\n

\nDr. Kristen Ambegaokar is a neurobiologist with 10+ years of diverse laboratory and clinical experience in neuroscience, molecular biology, and oncology. She holds a Bachelor of Arts in Neuroscience from Pomona College and received her PhD in Oncology from the University of California – Los Angeles, where she also served as a teaching assistant in Pharmacology. She completed her postdoctoral fellowship at the Fox Chase Cancer Center, where she developed new methods for analyzing neurons by flow cytometry to aid in the detection and quantification of relevant viral proteins and neuronal markers.\n<\/p>\n

\n\u201cWe are thrilled to have Kristen recognized by MM+M as a 40 under 40 honoree,\u201d says Pat McGloin, Chief Client Officer for MERGE. \u201cThis award is a demonstration of the amazing work that Kristen delivers for our clients each and every day. She truly embodies our core values of merging science with soul. Kristen has a unique ability to transform a breakthrough treatment’s dense scientific data and mechanism of action information into a well grounded story that’s approachable for all audiences. Our Life Science practice, and MERGE as a whole, is lucky to have Kristen on our team.\u201d\n<\/p>\n

\nIn addition to MERGE, this year\u2019s 40 Under 40 honorees hail from a range of the industry\u2019s biggest and most well respected organizations, including GoodRx, Real Chemistry, Janssen, Klick Health & GSK.\n<\/p>\n

\nThe 2023 MM+M 40 Under 40 class will be celebrated at a dinner to be held at The Edison Ballroom in New York City on February 16. For more information about MM+M\u2019s 40 Under 40 program, visit mmm40under40.com.<\/a>\n<\/p>\n

\nSince its founding in 1989, the MERGE team of poets + PhDs have built and supported successful healthcare brands. With over 100 successful pharmaceutical launches to date, MERGE has launched seven products in the last five years as the agency of record for new drug classes, challengers, and global brands.\n<\/p>\n

\nAbout MERGE<\/b>\n<\/p>\n

\nMERGE promotes health, wealth and happiness in the world by merging storytelling with technology and offers marketing and technology clients full-service capabilities including strategy, creative communications, experience engineering, performance marketing, media, digital platform development and more. MERGE has enduring client partnerships with American Express, T-Mobile, LG, Facebook, Adobe, Kate Spade NY, Coach, The North Face, Fidelity, Eaton Vance, BlueCross BlueShield, Abbott, Astellas, Seqirus, Supernus, Boston Scientific, Advocate Aurora Health, Indiana University Health and Marco\u2019s Pizza. With 750+ employees across offices in Atlanta, Boston, Chicago, Denver, Kansas City, Montreal, New York City and Los Angeles, MERGE uses a talent-to-task process that enables clients to think higher and feel deeper about their customers. For more information, visit mergeworld.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMolly Sullivan
\n
msullivan@mergeworld.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–MERGE, a premium storytelling and technology company, is proud to announce that Kristen Henkins Ambegaokar, PhD, Medical Director, Life Sciences, has been named to MM+M\u2019s fourth class of 40 Under 40 honorees. The 40 Under 40 list includes individuals who hail from a range of employers, from pharma and biotech companies and agencies to … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-51488","format-standard","category-industry"],"yoast_head":"\nMERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–MERGE, a premium storytelling and technology company, is proud to announce that Kristen Henkins Ambegaokar, PhD, Medical Director, Life Sciences, has been named to MM+M\u2019s fourth class of 40 Under 40 honorees. The 40 Under 40 list includes individuals who hail from a range of employers, from pharma and biotech companies and agencies to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-01T23:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221201006005\/en\/1653288\/21\/kristen-updated-headshot_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago\",\"datePublished\":\"2022-12-01T23:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/\"},\"wordCount\":614,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221201006005\\\/en\\\/1653288\\\/21\\\/kristen-updated-headshot_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/\",\"name\":\"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221201006005\\\/en\\\/1653288\\\/21\\\/kristen-updated-headshot_%281%29.jpg\",\"datePublished\":\"2022-12-01T23:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221201006005\\\/en\\\/1653288\\\/21\\\/kristen-updated-headshot_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221201006005\\\/en\\\/1653288\\\/21\\\/kristen-updated-headshot_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/","og_locale":"en_US","og_type":"article","og_title":"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–MERGE, a premium storytelling and technology company, is proud to announce that Kristen Henkins Ambegaokar, PhD, Medical Director, Life Sciences, has been named to MM+M\u2019s fourth class of 40 Under 40 honorees. The 40 Under 40 list includes individuals who hail from a range of employers, from pharma and biotech companies and agencies to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-01T23:02:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221201006005\/en\/1653288\/21\/kristen-updated-headshot_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago","datePublished":"2022-12-01T23:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/"},"wordCount":614,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221201006005\/en\/1653288\/21\/kristen-updated-headshot_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/","url":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/","name":"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221201006005\/en\/1653288\/21\/kristen-updated-headshot_%281%29.jpg","datePublished":"2022-12-01T23:02:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221201006005\/en\/1653288\/21\/kristen-updated-headshot_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221201006005\/en\/1653288\/21\/kristen-updated-headshot_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MERGE\u2019s Dr. Kirsten Ambegaokar Named To MM+M\u2019s 40 Under 40 List Chicago"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51488"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51488\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}